Shannon Campbell
Förmögenhet: 16 711 $ per 2026-09-30
Förmögenhet: 16 711 $ per 2026-09-30
Ms. Shannon Campbell is an Independent Director at Black Diamond Therapeutics, Inc. She is on the Board of Directors at Hansa Biopharma AB, Zentalis Pharmaceuticals, Inc. and Black Diamond Therapeutics, Inc. Ms. Campbell was previously employed as a Chief Commercial Officer & Executive VP by Merus NV and a Vice President & General Manager-Oncology by Bayer HealthCare Pharmaceuticals, Inc. She received her undergraduate degree from Ithaca College.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-26 | 8 865 ( 0,02 % ) | 16 711 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2024-04-10 |
| ZENTALIS PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2026-05-22 |
| HANSA BIOPHARMA AB | Direktör/Styrelseledamot | 2026-09-22 |
| Företag | Position | Slut |
|---|---|---|
| MERUS N.V. | Företagsledare/Principal | 2026-01-01 |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Företagsledare/Principal | 2017-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Ithaca College
Ithaca College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
Merus NV
Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Hansa Biopharma AB
Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån